While the company's margins dipped owing to discounts it offered to create demand, Insecticides still expects to benefit from economies of scale, says Rajesh Aggarwal, MD & CEO, Insecticides.
first published: Apr 12, 2016 12:55 pm
A collection of the most-viewed Moneycontrol videos.

Can Nifty Stage A Friday Fightback After Hitting 3-Week Low? Pine Labs IPO Opens | Opening Bell Live

Nifty Stays Below 25,600 Amid Expiry-Led Volatility; Grasim, Hindalco In Focus| Closing Bell Live

Pine Labs’ Rs 3,900 Cr IPO| CEO Amrish Rau On Why The Issue Size Was Cut & The Post-IPO Gameplan

Can Nifty Claw Back Above 25,600 Or Will Sensex Expiry Cap The Upside?| Opening Bell Live
You are already a Moneycontrol Pro user.


